(19)
(11) EP 1 084 236 A1

(12)

(43) Date of publication:
21.03.2001 Bulletin 2001/12

(21) Application number: 99927250.3

(22) Date of filing: 04.06.1999
(51) International Patent Classification (IPC)7C12N 15/00, C12N 5/00, A61K 48/00
(86) International application number:
PCT/US9912/548
(87) International publication number:
WO 9964/577 (16.12.1999 Gazette 1999/50)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 09.06.1998 US 88605 P
20.08.1998 US 97258 P

(71) Applicant: MERCK & CO., INC.
Rahway, New Jersey 07065 (US)

(72) Inventors:
  • MORSY, Manal, A.
    Rahway, NJ 07065 (US)
  • SANDIG, Volker
    Rahway, NJ 07065 (US)

(74) Representative: Horgan, James Michael Frederic et al
Merck & Co., Inc.,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) NOVEL ADENOVIRAL VECTORS FOR GENE THERAPY